
ãããµã¹ã®å»åž«ãCOVID-19ã¯ã¯ãã³ã®å±éºæ§ãæŽé²
BitChute Info that matters. 2021幎03æ20æ¥ããã
ãã€ã©ã€ãïŒ
ãCOVID-19ã¯ã¯ãã³ããšåŒã°ãããã®ã¯ãã¯ã¯ãã³ã§ã¯ãªã
å±éºãªå®éšçéºäŒåæ²»çã§ãã
COVIDææãã®ãã®ãããå±éºã§ããããšã倿ããŠãã
3幎åã«BANNED.VIDEOã§ãããå士ã®ãã®åç»ãèŠã€ããã©ãããŠãèš³ããããšæããŸããã
BANNED.VIDEOã®ãœãŒã¹åç»ããªããFirefoxããèŠããªããªã£ãŠããããã§ãBitChuteã«äžãã£ãŠããåç»ã䜿ã£ãŠããçŽããããŸããã
åœæã¯ç»é¢å€åå¹ãã¿ã€ã ã³ãŒãä»ã察蚳衚ãäœã£ãŠããããHTMLã®<video>ã§åå¹ã衚瀺ããŠããŸããã
<video>ã§è¡šç€ºãããåå¹ã¯ãµã€ãå æ€çŽ¢ã®å¯Ÿè±¡ã«å ¥ããªãã®ã§ãååã®æåèµ·ãããšç¿»èš³ã§ã¯ãåå¹å ã®æåæ å ±ã¯æ€çŽ¢ã§ããŸããã
ä»ããããå士ãèšã£ãŠããå®³ãæ¬¡ã ãšæãã¿ã«åºãŠããŸãã
ããã«ã¡ã¯ãç§ã¯ãããµã¹å·ãã¥ãŒã¹ãã³ã«ãããããä¿å¥ãšå¥åº·ã»ã³ã¿ãŒ(Hotze Health and Wellness Center)ã®åµèšè å ŒCEOãã¹ãã£ãŒãã³ã»ãããã§ãã
ãCOVID-19ã¯ã¯ãã³ããšåŒã°ãããã®ã¯ãã¯ã¯ãã³ã§ã¯ãããŸãããå±éºãªå®éšçéºäŒåæ²»çã§ãã
çŸç 管çã»ã³ã¿ãŒïŒCDCïŒã®ãŠã§ããµã€ãã«ã¯ãã¯ã¯ãã³ãšããçšèªã®å®çŸ©ãæ²èŒãããŠããŸããã¯ã¯ãã³ãšã¯ã人ã®å ç«ç³»ãåºæ¿ããŠç¹å®ã®ç æ°ã«å¯Ÿããå ç«ãäœãåºããã®ã§ããå ç«ãšã¯ææçãã身ãå®ãããšã§ããããç æ°ã«å¯Ÿããå ç«ãããã°ããã®ç æ°ã«ãããããŠãææããŸããã
ãã®COVID-19ã¯ã¯ãã³ãšåŒã°ãããã®ã¯ãã¯ã¯ãã³ãæ¥çš®ãã人ã«COVID-19ã«å¯Ÿããå ç«ãäžãããã®ã§ã¯ãªããç æ°ã®èå»¶ãé²ããã®ã§ããããŸãããCDCãå®ããã¯ã¯ãã³ã®å®çŸ©ã«åèŽããŠããªãã®ã§ãã
ããã«ãããã¯æ¬ºççååŒè¡çºãšèšããŸãããã®å®éšçãªéºäŒåæ²»çã補é ããŠãã補è¬äŒç€Ÿãããããã¯ã¯ãã³ã ãšäž»åŒµããããšã¯ãç±³åœé£éŠååŒå§å¡äŒïŒFederal Trade CommissionïŒã®åæ³15æ¡41é ã«åºã¥ã欺ççååŒè¡çºãªã®ã§ãã
補è¬äŒç€Ÿã¯åœæ°ã«åãã€ããŠããŸããæ¿åºã®ä¿å¥å®åããŸãããã®æ²»çæ³ãã¯ã¯ãã³ãšåŒã¶ããšã§åœæ°ã«åãã€ããŠããŸãã
ãã®COVID-19å®éšçéºäŒåæ²»çã¯ãCOVID-19ãŠã€ã«ã¹ã«ææããå Žåã®çç¶ãæå°éã«æããããã®ãã®ã§ãããããŸããã
ããäžåºŠåŒ·èª¿ããŠãããŸããããã®COVID-19å®éšçéºäŒåæ²»çã¯ãã¯ã¯ãã³ãšã¯äœããšããCDCèªèº«ã®å®çŸ©ãæºãããŠããªãã®ã§ããå ç«ãäžãããã®ã§ã¯ãªããç æ°ã®èå»¶ãé²ããã®ã§ããªãã
ãã®æ²»çæ³ããã¯ã¯ãã³ããšåŒã¶ããšã§ã補è¬äŒç€Ÿã¯èªããå®ãããšããŠããŸãããªããªããã¯ã¯ãã³ã«ããå·å®³ãæ»äº¡ã¯ã補é ç©è²¬ä»»èšŽèšã®å¯Ÿè±¡ããæ³åŸã§é€å€ãããŠããããã§ãã
ç±³åœã®ä¿å¥å®åãã¡ã¯ãCOVID-19ã¯ã¯ãã³ãšåŒã°ãããã®æ²»çæ³ãæ¥ãããã§é²ããããããã¯ãŒãã»ã¹ããŒãäœæŠããéå§ããŸããã2020幎12æ11æ¥ãFDAã¯ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³ãæ¿èªãããã®ããã1é±éåŸã«ã¢ãã«ãã®ã¯ã¯ãã³ãæ¿èªãããŸããã
ãããã®ã¯ã¯ãã³ãšåŒã°ãããã®ã¯ãåç©å®éšãé·æã«ãããããã§ã®ç ç©¶ãçµãã«æ¿èªãããŸãããã€ãŸãããããã®éºäŒåæ²»çã¯ã¯ãã³ãšåŒã°ããå®éšçæ²»çãåãã人ã¯ãã¢ã«ã¢ãããªã®ã§ããããã人éãã¢ã«ã¢ããã«ãªãã
ãããã®ã¯ã¯ãã³ãšåŒã°ãããã®ã¯ã1970幎代ã«äžçµ¶ãããããã®èå ç±æ¥ã®çްèã䜿ã£ãŠè£œé ãããŠãããæ£ç¢ºã«ã¯å®éšçéºäŒåæ²»çãšåŒã¶ã¹ããã®ã§ããCOVID-19ãããã¯ããã«å€§ããªå±éºãšãªã¹ã¯ãå¥åº·ã«ãããããæªæ€æ»ãæªèšŒæã®å®éšçéºäŒåæ²»çãªã®ã§ãã
ã¢ãã«ãã¯ãããµãã¥ãŒã»ããå·ã±ã³ããªããžã«ããæè¡ç³»è£œè¬äŒç€Ÿã§ã2010幎ã«ModeRNA TherapeuticsãšããŠèšç«ãããŸãããModernaã®èªæºã¯ããã«ãããŸããCOVID-19ãå«ãæ§ã ãªçŸæ£ã®æ²»çã®ããã«ãåæmRNAãçšããå®éšçéºäŒåæ²»çãéçºããŠããŸããã
ããã§æ¬åœã«éèŠãªããšããããŸããéå»10幎éã¢ãã«ãã¯ä»ãŸã§ã«ããããªãçŸæ£ã®æ²»çè¬éçºã«ãæåããããšã¯ãããŸããã
ææçãæ²»çããããã®åæmRNAãçšããå®éšçéºäŒåæ²»çã¯ãããã§è©Šã¿ãããããšã¯äžåºŠããããŸããããªããïŒãåç©å®éšã§å€±æããããã§ãã
åŸæ¥ã®ã¯ã¯ãã³ã®çè«ã¯ãæææ§ã®ãŠã€ã«ã¹ã现èã®ã¿ã³ãã¯è³ªãå°éäœå ã«æ³šå°ããããšã§ãçµæãšããŠãå ç«ç³»ããã®ææåŸ®çç©ã«å¯Ÿããæäœãç£çããå ç«åãç²åŸãããšãããã®ã§ãã
æ°ããCOVID-19ãšåŒã°ããã¯ã¯ãã³ã¯ã¯ã¯ãã³ã§ã¯ãããŸãããããã¯mRNAãšåŒã°ããåæã¡ãã»ã³ãžã£ãŒã»ãªãæ žé žã§ãã
ããã¯å®éšçãªéºäŒåæ²»çã§ãããæŽå²çãªã¯ã¯ãã³ãšã¯ããªãç°ãªãåããããŸãããã®æ¹æ³ã®çè«ã¯ããã£ããåæmRNAãäœå ã«æ³šå ¥ããããšããããã¯èªãã现èå ã«æ¿å ¥ãã现èãã³ãããŠã€ã«ã¹ã®ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãç£çãå§ãããšãããã®ã§ãã
ããã§ããããªãã®çްèã¯ãèªåã®DNAããäœãããããã§ããªããã®åæmRNAããæŒãã€ããããããšã«ãªãã®ã§ãããããä»ãã³ãããŠã€ã«ã¹ã®ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãäœãããšããŠããŸãã
ãªããããªããšããããã®ãïŒãããããªããå®å šã«å¥åº·ãªãããªã倿¥ã®mRNAãæ³šå ¥ãããã®ã§ããããïŒ
äºæ³ãããããšã¯ãèªèº«ã®çްèã«ãã£ãŠäœããããã®ã³ãããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã«å¯Ÿããæäœããããªãã®äœãäœãå§ãããšããããšã§ãã
现èããã€ãŸã§ãã®ãŠã€ã«ã¹ã»ã¿ã³ãã¯è³ªãç£çããã®ãããããã¯ç£çãæ¢ãŸããã©ããã¯ããããªãã®ã§ããå ç«ç³»ã¯ãèªåã®äœãåžžã«ç£çããŠãããããã®ãŠã€ã«ã¹ã¿ã³ãã¯è³ªãæéããªããã°ãªããªãã®ã§ã亢é²ããã§ãããã
ãããŠãããããã®æç¹ã§ã³ãããŠã€ã«ã¹ã«ææããæãéå°ã«åå¿ããŠããŸãã§ãããããããã2005幎ãš2012幎ãmRNAå®éšçéºäŒåæ²»çãä»ã®ã¿ã€ãã®ã³ãããŠã€ã«ã¹ã®åç©å®éšã«äœ¿ããããšãã«èµ·ãã£ãããšã§ããåç©ãã¡ã¯ã以åã«ã¯ã¯ãã³æ¥çš®ãåããã³ãããŠã€ã«ã¹ã«æé²ããããšãå ç«ç³»ã®éå°åå¿ã«ãã£ãŠæ»ã«ãŸããããã®éå°åå¿ã¯æäœå¢åŒ·åå¿ãšåŒã°ããŸãã
ãã®mRNAã¯ã¯ãã³ã¯ãããã«äœ¿çšãããåããŠã®ãã®ã§ãããããŸãåç©å®éšã§å®å šæ§ã確èªãããŠããã¯ãã§ãããããŠãã¯ã¯ãã³ã«ã¯éåžžå¿ èŠãšããããå°ãªããšã2幎éã®ããã§ã®è©Šéšãå¿ èŠã§ãã
ãããªã®ã«ãCOVID mRNAãšåŒã°ããã¯ã¯ãã³ã¯2ã3ã¶æããããã§ãã¹ããããŠããŸãããå šäººå£ãžã®å€§éæ¥çš®ãæšå¥šããåã«ãé·æã«ããã人äœç ç©¶ãè¡ãã®ãè³¢æã ã£ãã®ã§ã¯ãªãã§ããããïŒ
ç±³åœã§ã¯äœ¿çšéå§åŸ1ãµæéã«4äžä»¶ä»¥äžã®å¯äœçšãå ±åãããŠããããã®äžã«ã¯ã¢ããã£ã©ãã·ãŒã·ã§ãã¯ãé節ãªç¥çµéå®³ãæ°åäŸå«ãŸããŠããŸãã宿çã«äºé²æ¥çš®å§å¡äŒã«å ±åãããå¯åå¿ã®ä»¶æ°ã¯10ïŒ ã«æºããªãã®ã§ãäœåäžä»¶ãã®æ³šå°ã«ãã被害ãçºçããŠããå¯èœæ§ãé«ãã®ã§ãã
æåã®30æ¥éã ãã§ãã®ä»¶æ°ã§ãã2æ14æ¥çŸåšããã®å®éšçéºäŒåæ²»çãããããã¯ã¯ãã³ãæ¥çš®ããäººã®æ»è ã¯934人ã§ããã®äžã«ã¯éçã®åéžæãã³ã¯ã»ã¢ãŒãã³ãå«ãŸããŠããŸãã
ç§ãç¥ããªãéã«ãã®ã¯ã¯ãã³ãæ¥çš®ãã2æ¥ä»¥å ã«æ»äº¡ãã人ãäœäººãç¥ã£ãŠããŸããããã¯å¶ç¶ã§ã¯ãããŸããã
ããã«å¿é ãªã®ã¯ããã®å®éšçéºäŒåæ²»çã«ããé çºæ§ã§é·æçãªå¯äœçšã§ããåæmRNAå®éšçéºäŒåæ²»çã¯COVID-19ã¿ã³ãã¯è³ªã®ç£çããªã³ã«ããŸããããªãã¹ã€ããã¯ãããŸãããè€è£œãç¶ããå ç«ã·ã¹ãã ã¯ããã«å¯Ÿããå ç«åå¿ãèµ·ããç¶ããã®ã§ãã
ãã®ããç ç©¶è ã®äžã«ã¯ãèªå·±å ç«åå¿ãèµ·ããããšã«ãã£ãŠãçæ¶¯ã«ãããé節ãªççæ§çŸæ£ãåŒãèµ·ããããã®ã§ã¯ãªããããšå¿é ãã人ãããŸãã
ããäžã€ã®å€§ããªæžå¿µã¯ãCOVID-19å®éšçéºäŒåæ²»çãææçãããã«æªåãããå¯èœæ§ã§ãããã®å®éšçéºäŒåæ²»çã¯æäœäŸåæ§å¢åŒ·åå¿ãåŒãèµ·ãããããããªãããšãã説åŸåã®ããè°è«ããããŸãããã®çµæããŠã€ã«ã¹ã现èã«ææããèœåãé«ãŸãã®ã§ããèšãæããã°ãå®éšçéºäŒåæ²»çã®æ³šå°ãåããåŸãå°æ¥ã³ãããŠã€ã«ã¹ææçã«ããã£ãå Žåããããããã®æ²»çãåããªãã£ãå Žåãããã¯ããã«æªãçäŸã«ãªãå¯èœæ§ããããšããããšã§ãã
ããã¯æ²»çãç æ°ããæªãå Žåã§ãããã©ãããã®å®éšçéºäŒåæ²»çã¯ãããã§ããããã«èŠããŸããå€ãã®å°éå®¶ã¯ããã®æ²»çãåãã人ã ã®çåœãè ããææçãççæ§çŸæ£ãæ»äº¡ãæ°ãµæåŸãæ°å¹ŽåŸã«æ¥å¢ãããšäºæž¬ããŠããŸã
ãã¡ãããã®è²¬ãã¯ãå®éšçéºäŒåæ²»çã®ããã§ã¯ãªããCOVID-19ãŠã€ã«ã¹ã®å€ç°ããåŒ·æ¯æ ªã®ããã«ãããã§ãããããããŠãå šãŠã®äººã«ã¯ã¯ãã³æ¥çš®ã矩åä»ããããšããã§ãããã
ä»®ã«ãããèªãããããšããŠãããããŸã§COVID-19ã¯ã¯ãã³ã«120åãã«ä»¥äžãè²»ãããŠããã¢ã¡ãªã«æ¿åºã¯ããã®æ²»çãåãã人ã ã被ã£ãæå®³ã®ãã±ãæãããšã«ãªããŸããåã«è¿°ã¹ãããã«ãæ³åŸäžã補è¬äŒç€Ÿã¯ã¯ã¯ãã³ã«ãããããªãå·å®³ã«å¯ŸããŠã蚎ããããããšã¯ãããŸãããã€ãŸããåãã€ããŠãã®å®éšçéºäŒåçæ³ãã¯ã¯ãã³ãšåŒã¶ããšã§ã補è¬äŒç€Ÿã¯è£œé 責任ã®ãªã¹ã¯ãè² ãããšãªãè«å€§ãªå©çãåŸãŠããã®ã§ãã
ã¡ãã£ã¢ã¯COVID-19éºäŒåæ²»çã®å¯äœçšã軜èŠããŠããã ãã§ãªãã補è¬äŒç€Ÿã®æ¥œèгçãããæå¹æ§ã®äž»åŒµãç¹°ãè¿ãã ãã§æºè¶³ããŠããããã§ãããã¡ã€ã¶ãŒãšã¢ãã«ãã®ã¯ã¯ãã³ã¯95ïŒ æå¹ã ãšèããããšãããã§ããããããã¯èåœã®äž»åŒµãåãªã®ã§ãã
ããããå»åŠçã®æš©åšãæ¿åºå®åã¯ããããã®è£œè¬äŒç€Ÿã®èšèãéµåã¿ã«ããŠããã®å®éšçéºäŒåæ²»çãããããã¯ã¯ãã³æ¥çš®ã«äžŠã¶ããçã«å§ããŠããŸãã
ãã¡ã€ã¶ãŒãšã¢ãã«ãã®è£œåãæ¿èªãããæç¹ã§ã¯ããããã®è£œè¬äŒç€Ÿã¯å®éšçãªèšåºè©Šéšã®çããŒã¿ã®æ®ã©ãå ¬è¡šããŠããŸããã§ãããå®éãçŸåšããã®å€ãã¯å ¬è¡šãããŠããŸããã
ããããããå€ãã®ããŒã¿ãå ¬éãããããã«ãªã£ãä»ããããŸã§ãšã¯ç°ãªãå§¿ãæµ®ãã³äžãã£ãŠããŸãããããªãã£ãã·ã¥ã»ã¡ãã£ã«ã«ã»ãžã£ãŒãã«èªã®å¯ç·šéé·ã§ããããŒã¿ãŒã»ããŒã·å»åž«ã¯ãå ¥æå¯èœãªããŒã¿ãæ€èšããæ©äŒãåŸãŠãæ¿èªåèšåºè©Šéšã®ççŸãšåŒ±ç¹ãææããŸããã
圌ã®çµè«ã¯ãåºã宣äŒãããŠãã95ïŒ ã®æå¹çã§ã¯ãªãããããã®ã¯ã¯ãã³ãšåŒã°ãããã®ã¯ãããã19ïŒ ãããªããšãããã®ã§ãããïŒãšïŒãæå¹ç19%ããã®äœçã§ã¯ãæ¿èªãããããšã¯ãªãã£ãã§ãããã
ãã®å®éšçéºäŒåæ²»çã«ã€ããŠã¯ããŸã äžæãªç¹ããããããããŸããæåœãæææ¡å€§ã®é²æ¢ããããã¯ææçã«çœ¹ãã®ãé²ãã ãšããå åã¯ãããŸãããã§ãããä¿å¥å®åãã¡ã¯ããã®æ³šå°ãåããåŸã§ãããã¹ã¯ã®ççšãšç€ŸäŒçè·é¢ã®ä¿æãæšå¥šãç¶ããŠããã®ã§ãããã®å®éšçéºäŒåæ²»çã®é·æçãªå¯äœçšã«ã€ããŠã¯ã誰ãç¥ããŸããã
ããã§ã圌ãã¯ããã®å®éšçéºäŒåæ²»çãå šäººå£ã«æ³šå ¥ããèšç»ãé²ããŠããŸãã
ã€ã³ãã«ãšã³ã¶ã»ã¯ã¯ãã³ãã€ã³ãã«ãšã³ã¶ãé§éããªãã®ãšåæ§ããã®å®éšçéºäŒåæ²»çãCOVID-19ã®åå ã§ããã³ãããŠã€ã«ã¹ãæ ¹çµ¶ããããšã¯ãããŸãããCOVID-19ã¯ãããšããã®ã¯ã¯ãã³ãšåŒã°ãããã®ããªããŠããããå€ããèªç¶éå£å ç«ãç²åŸããã«ã€ããŠææã¯ç·©ããã«ãªããä»åŸãååšãç¶ããã§ãããã
ãªãäžã®äžã§ãå®éšçéºäŒåæ²»çã®ãæ¢ç¥ããã³æªç¥ãçæçããã³é·æçãªå¯äœçšã®ãªã¹ã¯ãåãå¿ èŠãããã®ã§ããããïŒãããã¯ååãªæ€èšŒãçµãŠããŸããããã®éºäŒåæ²»çã¯æ¿èªããã»ã¹ãã¯ãŒãã¹ããŒãã§é§ãæããåœåçŽæãããŠãããããã¯ããã«å¹æãäœãããããCOVIDææãã®ãã®ãããå±éºã§ããããšã倿ããŠããŸãã
ç§ã¯èªåã®å®¶æãå人ããããŠããããããä¿å¥ãšå¥åº·ã»ã³ã¿ãŒãã®æ¥å®¢ã«ããã äžèš ããããããšèšãããã«ã¢ããã€ã¹ããŠããŸãããããããç§ã¯ãã®å®éšçéºäŒåæ²»çã¯ã¯ãã³ãåããã€ããã¯ãããŸãããã
COVID-19ææçã¯ãç 匱ãªé«éœ¢è ãéç¯€ãªæ¢åŸçã®ãã人ãé€ãã°ãã€ã³ãã«ãšã³ã¶ãä»ã®åŒåžåšææçãšã¯ç°ãªããé倧ãªå¥åº·è¢«å®³ãããããããšã¯ãããŸãããCOVID-19ã«ææããäººã®æ®ã©ã¯ãã€ã³ãã«ãšã³ã¶ã«äŒŒã軜床ãŸãã¯äžç床ã®çç¶ãæ°æ¥éç¶ããŸãããææè ã®å šçåçã¯99.98ïŒ ã§ããè匱äœè³ªãé«éœ¢è ãæ¢åŸçã®ãã人ãé€ãã°ãæ»ã«è³ãããšã¯ãã£ãã«ãããŸããã
ã€ãã«ã¡ã¯ãã³ãšããããã·ã¯ãããã³ã䜿çšããããšã§ãCOVID-19ææãå®å šã«äºé²ã»æ²»çã§ããããšãäžçäžã®ç ç©¶ã§èšŒæãããŠããŸãã
ãã¡ãããããªãèªèº«ã®å ç«åã匷åããããšã倧åã§ãããã¿ãã³ãããã©ã«ã®è£çµŠãå¥åº·çãªé£äºãèªç¶ãªãã«ã¢ã³ã®è£å ãã¢ã¬ã«ã®ãŒã®æ²»çãéåãšè³ªã®è¯ãç¡ç ãçæ³çãªäœéã®ç¶æãªã©ã§å ç«åãé«ããã®ã§ãã
ããã¯ããŠããããã®ãŠã€ã«ã¹ã瀟äŒã§ãã®åœ¹å²ãçµããã®ãåŸ ã¡ãŸãããããšããã®ã¯ãéå£å ç«ãçºéãããããã§ãããã®å®éšçéºäŒåæ²»çãããã¯ããã«å®å šã§å¹æçã§ãã
æ¿åºã®ä¿å¥å®åãã¡ãã£ã¢ãæ¿æ²»å®¶ãäœãåºãããããã¯ãšéå£ãã¹ããªãŒã¯ãå šãŠæ¯é ãšæš©åãšéã®ãããªã®ã§ããç§ã¯ãããŸã§ããã¹ã¯ã®ççšã瀟äŒçè·é¢ã®åãæ¹ãäŒæ¥ã®ééãããã¯ããŠã³ã®éå¹çæ§ãå±éºæ§ã«ã€ããŠãäœåºŠãæžããŠããŸãããç§ãã¡ã¯ä»äºã«æ»ããåŠæ ¡ã«æ»ããæäŒã«æ»ããªããã°ãªããŸããã
ã¹ãã£ãŒãã³ã»ããããã話ããŸããããèŠèŽããããšãããã®ãããªããå®¶æããå人ããç¥ãåãããããŠãä»ãåãã®ããæ¹å šå¡ã«ãäŒãäžãããäžè¬å€§è¡ã«æŒãã€ããããããšããŠãããã®å®éšçéºäŒåæ²»çããã°ã©ã ã®å±éºæ§ã«ã€ããŠèŠåããŠããã ããããšæããŸãããã®å®éšçéºäŒåçæ³ã«ã€ããŠç§ãæžããææžã®ã³ããŒãéã£ãŠãããã§ãã
æ¬æ¥ã¯ããããšãããããŸãããããªãã®å¥åº·ãšäººçããããŠç§ç掻ã§ã®æåããç¥ãããŠããŸãããã¯ã¿ãŒã»ãããããæè¬ã蟌ããŠã